Navigation Links
EaglePicher Technologies Receives Battery Power Products and Technology's First Annual Innova Award

Medical Group's Micro Battery Wins for Industry Leadership

JOPLIN, Mo., Jan. 7 /PRNewswire/ -- EaglePicher Technologies, LLC, an EaglePicher company, today announced its Medical Power group has received Battery Power Products and Technology's first annual Innova Award. The company received honors in the Industry Leadership category for its Micro Battery -- the world's smallest implantable medical-grade battery.

The Innova Award recognizes companies that are striving for excellence and achieving technology breakthroughs. EaglePicher's Micro Battery was recognized as an Industry Leader because of its promise of impacting the medical device industry by allowing implantable medical devices to be created even smaller than current commercial offerings.

The Micro Battery, at 0.260" long x 0.090" diameter, is at least 50% smaller and lighter than other commercially available products and can be deployed via a minimally-invasive catheter procedure rather than traditional implantation surgery. Electrical capacity exceeds the original design objective by a factor of five with the result that it can theoretically power the device for more than 15 years.

The Micro Battery will create new opportunities for device manufacturers in Neurological Stimulation, Brain Computer Interfaces, Cardiovascular Monitoring, and Neural Prostheses (Retinal implants, Cochlear implants) by allowing them to create smaller, more efficient devices.

"EaglePicher is honored to receive this recognition from Battery Power Products and Technology," said Marcela Gavril, director of product development, EaglePicher Technologies/Medical Power. "We are extremely proud of the Micro Battery, what it will do for the industry and most importantly, what it means to those who will benefit from the devices it powers."

EaglePicher Technologies, LLC, an EaglePicher company, is the leading producer of batteries and energetic devices for the defense, space and commercial industries, and provides the most experience and broadest capability in battery electrochemistry of any battery supplier in the United States. EaglePicher Technologies offers a wide range of battery technology including thermal, nickel hydrogen, lithium carbonmonofluoride, lithium thionyl chloride, lithium manganese dioxide, lithium sulfur dioxide, lithium ion, reserve lithium oxyhalide, custom battery assemblies and silver zinc batteries. It also provides other energy products and pyrotechnic devices for the defense industry, as well as advanced battery chargers and other power solutions for business, industrial and recreational applications. EaglePicher Technologies is headquartered in Joplin, Mo., and is an AS9100 certified supplier. For more information, visit

About EaglePicher Medical Power

EaglePicher Medical Power is a world-leading supplier of batteries to manufacturers of implantable medical devices. Products include batteries for cardio defibrillators, heart monitors, heart re-synchronizers and neuromodulation systems.

EaglePicher Medical Power is one of the few producers of implantable-grade batteries in the world to be certified ISO 13485, and leads the industry in producing rechargeable lithium-ion batteries for implantable applications.

Building upon the world-class technology heritage of parent EaglePicher, the company offers one of the broadest ranges of electrochemistries for implantable applications including lithium-ion, lithium manganese dioxide, lithium thionyl chloride and lithium carbon monofluoride.

SOURCE EaglePicher Technologies, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Clarient CEO Ron Andrews to Participate in OneMedPlace Emerging Healthcare Technologies Finance Forum
2. GSA Selects Cascades Technologies, Inc. (CTi) to Support
3. MultiCell Technologies To Increase Focus on Therapeutic Candidates
4. Senesco Technologies Closes on Additional $4.0 Million of Previously Announced Financing
5. Neurobiological Technologies, Inc. Reports Retirement of Ronald E. Cape, Ph.D., from Board
6. ISTO Technologies to Present at OneMedPlace Finance Forum
7. Siemens Building Technologies Helping Companies Participate in EPA Labs21 Movement With Comprehensive Compliance Solution Strategy
8. Announces Upcoming Interview With CEO of ReBuilder Medical Technologies
9. Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program
10. Healthcare Technologies, Ltd. Receives Notice From Nasdaq
11. CVF Technologies Corporations Holding - BIOREM Announces 3rd Order from China
Post Your Comments:
(Date:6/23/2016)... HOUSTON , June 23, 2016 ... agreement with the Cy-Fair Sports Association to serve ... of the agreement, Houston Methodist Willowbrook will provide ... education and connectivity with association coaches, volunteers, athletes ... partner with the Cy-Fair Sports Association and to ...
(Date:6/23/2016)...   EpiBiome , a precision microbiome engineering company, ... financing from Silicon Valley Bank (SVB). The financing will ... its drug development efforts, as well as purchase additional ... has been an incredible strategic partner to us – ... would provide," said Dr. Aeron Tynes Hammack , ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, ... Pennsylvania Convention Center and will showcase its product’s latest features from June 26 ... presenting a scientific poster on Disrupting Clinical Trials in The Cloud during the ...
Breaking Biology Technology:
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... BOCA RATON, Florida , March 29, 2016 /PRNewswire/ ... ("LegacyXChange" or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect ... Synthetic DNA in ink used in a variety of ... preventing theft. Buyers of originally created collectibles from athletes ... authenticity through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):